PHIO FY 2022 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$7M

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$-89.61

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$414,000

Balance Sheet

Total Assets

$13M

Total Liabilities

$2M

Stockholders' Equity

$11M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$7M	-$9M	+21.1%
Operating Income	-$11M	-$14M	+15.2%
Net Income	-$11M	-$13M	+13.6%